Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OMGA Omega Therapeutics > Company Executives
OMGA Omega Therapeutics
6.770
-0.220-3.15%
Post Mkt Price
6.7700.0000.00%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Mahesh KarandePresident, Chief Executive Officer and Director4.70M----49male04/29/2022
Dr. Thomas McCauley, PhDChief Scientific Officer1.32M----53male04/29/2022
Mr. Joshua ReedChief Financial Officer------49male04/28/2022
Dr. Yan MooreChief Medical Officer------56male04/29/2022
Ms. Ling Zeng, J.D.Chief Legal and Administrative Officer------53female04/29/2022
Dr. Roger SawhneyChief Financial Officer and Principal Accounting Officer981.22K----52male04/29/2022
Mr. Kevin McManusChief Human Resources Officer------54male04/29/2022
Dr. Noubar B. Afeyan, PhDChairman of the Board255.59K----59male04/29/2022
Mr. Luke M. BesharIndependent Director636.24K----63male04/29/2022
Ms. Mary T. SzelaIndependent Director29.85K----58female04/29/2022
Dr. John D. Mendlein, PhDIndependent Director27.10K----62male04/29/2022
Dr. Richard A. Young,PhDIndependent Director143.28K----68male04/29/2022
Mr. Rainer Boehm, M.B.A.,M.D.Independent Director--------male09/01/2022
Dr. Elliott M. Levy, M.D.Independent Director229.75K----63male04/29/2022
Company Overview More
Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
CEO: Mr. Mahesh Karande
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist